Given the role in cell proliferation, angiogenesis and fibrosis upon inflammation, and considering that they are hallmarks of tendinopathy, targeting the CX3CL1/CX3CR1/EREG axis could potentially open up new vistas in tendinopathy therapy. The gene discussed is CX3CL1; the disease is disease of the tendon.